Adolfo Jiménez-Huete1, Susana Estévez-Santé2. 1. Department of Neurology, Hospital Ruber Internacional, C/La Masó, 38, 28034 Madrid, Spain. Electronic address: ajimenez@ruberinternacional.es. 2. Department of Neurology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
Abstract
BACKGROUND/AIMS: Alzheimer's disease (AD) shows a characteristic pattern of brain atrophy, with predominant involvement of posterior limbic structures, and relative preservation of rostral limbic and primary cortical regions. We aimed to investigate the diagnostic utility of two gray matter volume ratios based on this pattern, and to develop a fully automated method to calculate them from unprocessed MRI files. PATIENTS AND METHODS: Cross-sectional study of 118 subjects from the ADNI database, including normal controls and patients with mild cognitive impairment (MCI) and AD. Clinical variables and 3T T1-weighted MRI files were analyzed. Regional gray matter and total intracranial volumes were calculated with a shell script (gm_extractor) based on FSL. Anteroposterior and primary-to-posterior limbic ratios (APL and PPL) were calculated from these values. Diagnostic utility of variables was tested in logistic regression models using Bayesian model averaging for variable selection. External validity was evaluated with bootstrap sampling and a test set of 60 subjects. RESULTS: gm_extractor showed high test-retest reliability and high concurrent validity with FSL's FIRST. Volumetric measurements agreed with the expected anatomical pattern associated with AD. APL and PPL ratios were significantly different between groups, and were selected instead of hippocampal and entorhinal volumes to differentiate normal from MCI or cognitively impaired (MCI plus AD) subjects. CONCLUSION: APL and PPL ratios may be useful components of models aimed to differentiate normal subjects from patients with MCI or AD. These values, and other gray matter volumes, may be reliably calculated with gm_extractor.
BACKGROUND/AIMS: Alzheimer's disease (AD) shows a characteristic pattern of brain atrophy, with predominant involvement of posterior limbic structures, and relative preservation of rostral limbic and primary cortical regions. We aimed to investigate the diagnostic utility of two gray matter volume ratios based on this pattern, and to develop a fully automated method to calculate them from unprocessed MRI files. PATIENTS AND METHODS: Cross-sectional study of 118 subjects from the ADNI database, including normal controls and patients with mild cognitive impairment (MCI) and AD. Clinical variables and 3T T1-weighted MRI files were analyzed. Regional gray matter and total intracranial volumes were calculated with a shell script (gm_extractor) based on FSL. Anteroposterior and primary-to-posterior limbic ratios (APL and PPL) were calculated from these values. Diagnostic utility of variables was tested in logistic regression models using Bayesian model averaging for variable selection. External validity was evaluated with bootstrap sampling and a test set of 60 subjects. RESULTS: gm_extractor showed high test-retest reliability and high concurrent validity with FSL's FIRST. Volumetric measurements agreed with the expected anatomical pattern associated with AD. APL and PPL ratios were significantly different between groups, and were selected instead of hippocampal and entorhinal volumes to differentiate normal from MCI or cognitively impaired (MCI plus AD) subjects. CONCLUSION:APL and PPL ratios may be useful components of models aimed to differentiate normal subjects from patients with MCI or AD. These values, and other gray matter volumes, may be reliably calculated with gm_extractor.
Authors: M J de Leon; A Convit; S DeSanti; M Bobinski; A E George; H M Wisniewski; H Rusinek; R Carroll; L A Saint Louis Journal: Int Psychogeriatr Date: 1997 Impact factor: 3.878
Authors: Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson Journal: Brain Date: 2007-02-09 Impact factor: 13.501
Authors: Michael S Mega; Gary W Small; Mina L Xu; Jenaro Felix; Mario Manese; Nha P Tran; Jason I Dailey; Linda M Ercoli; Susan Y Bookheimer; Arthur W Toga Journal: Psychosom Med Date: 2002 May-Jun Impact factor: 4.312
Authors: M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen Journal: Neurology Date: 1996-03 Impact factor: 9.910
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Manuel Menéndez González; Esther Suárez-Sanmartin; Ciara García; Pablo Martínez-Camblor; Eric Westman; Andy Simmons Journal: Cureus Date: 2016-03-26
Authors: Lisa Mosconi; Alberto Pupi; M Teresa R De Cristofaro; Mozghan Fayyaz; Sandro Sorbi; Karl Herholz Journal: J Nucl Med Date: 2004-03 Impact factor: 10.057